ORLINT & ORLEXT: Orthosis for Knee
Condition(s) studied
Investigational drug(s) / intervention(s)
Orlint-Orlext orthosis device: Participants must wear the new knee orthosis during assessments and in their daily lives for at least one month, which is the duration of the study.
Conventional orthosis device: Participants must wear the conventional knee orthosis and without orthosis, during assessments and before wearing the new one
Study summary
The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with lateral ligament knee lesions of both sexes and older than 18 years old. The main question it aims to answer is:
Is the new orthosis a support for knee stability?? Does the new orthosis improve knee function and patients' quality of life??
The control group will be the subjects themselves when wearing their conventional knee orthosis or without it.
Participants must wear the new knee orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the knee joint and muscles.
Eligibility
Primary outcome measure(s)
- Device feasibility — Baseline and up to 4 weeks
Device feasibility will be assessed through participants' awareness of the device, as an indicator of its accessibility, visibility, and potential for effective implementation within the target population. A self-diary will be requested
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Salamanca | Salamanca | Salamanca |
More University of Salamanca trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07333911 on ClinicalTrials.gov ↗ ← All trials in Spain